UNSPSC 51123001: Ajmaline

This classification denotes an antiarrhythmic agent with the molecular formula C20H26N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1PON08459R, chemically known as ajmalan-17,21-diol, (17r,21.alpha.)- but more generally known as ajmaline, which bears US NIH Compound Identifier 2073. Ajmaline comes in many forms, including aspartate, ethanolate, ethylphenylbarbiturate, n-oxide, and phenylbarbiturate.

UNSPSC 51123001 Ajmaline, a Commodity code, does not align with the state and local contract opportunities recently posted under this code. The three most recent solicitations—from the City of Tampa Fire Rescue, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance—all involve broadly sourced advanced life support medications, prescription programs, and multi-source generic pharmaceuticals and over-the-counter products. None of these opportunities specifically procure ajmaline, a cardiac arrhythmia medication, as a line item or named pharmaceutical. The code appears to show limited recent activity directly tied to ajmaline procurement; state and local governments are instead buying across broader pharmaceutical families under cooperative purchasing vehicles and municipal health-emergency procurement.

The geographic spread spans Texas, Minnesota (with Oregon participating through MMCAP), and Florida. The City of Tampa's IFB for Advanced Life Support Medications (Bid No. 26-P-00188, due April 8, 2026, with an estimated contract value of $40,000.00) is representative of municipal emergency-services pharmaceutical sourcing, while the Minnesota Department of Administration's RFP through MMCAP (due March 26, 2026) demonstrates state-led cooperative purchasing for multi-source generics across multiple jurisdictions. The Texas HHS Commission's RFI (HHS0017013, posted April 3, 2026) signals exploratory procurement for direct-to-manufacturer pharmacy programs. Issuing bodies include municipal purchasing departments, state health agencies, and cooperative purchasing alliances; repeat buyers at scale use cooperative vehicles such as MMCAP to aggregate demand across member jurisdictions. Recent opportunities show no set-aside designations other than Tampa's 5 percent Small Local Business Enterprise bid discount, and no ajmaline-specific procurement signals emerge from the available source material.